Drugmaker to sell cheaper generic rival to EpiPen injectors

A Swiss drugmaker is challenging a 2011 change to the law that no longer allows a company to patent an invention if it was for sale for more than a year before filing a patent application. Meanwhile, Congress also plans to focus on the issue of pharmaceutical patents and lawmakers continue to question the industry's pricing decisions. And as Capitol Hill gears up for potential action on drug costs, there may be some lessons to be learned from China.

Drugmaker to sell cheaper generic rival to EpiPen injectors

A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

Thu 6 Dec 18 from Medical Xpress

Generic drugmaker to sell alternative to EpiPen injectors

Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year.

Fri 7 Dec 18 from FOXNews

Generic Drugmaker to Sell Alternative to EpiPen Injectors, Fri 7 Dec 18 from Laboratory Equipment

Small Drug Companies Closely Watching Supreme Court Case On Patents

A Swiss drugmaker is challenging a 2011 change to the law that no longer allows a company to patent an invention if it was for sale for more than a year before filing a patent application. Meanwhile, ...

Fri 7 Dec 18 from Kaiser Health News

  • Pages: 1

Bookmark

Bookmark and Share